LGT Group Foundation Has $5.56 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

LGT Group Foundation lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,526 shares of the company’s stock after purchasing an additional 312 shares during the quarter. LGT Group Foundation’s holdings in HCA Healthcare were worth $5,561,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $31,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth $39,000. Activest Wealth Management boosted its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $41,000. Finally, Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.6 %

Shares of HCA stock opened at $311.11 on Tuesday. The stock has a market cap of $77.26 billion, a price-to-earnings ratio of 14.16, a P/E/G ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a fifty day moving average of $315.30 and a 200-day moving average of $348.80. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.93%. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Analyst Upgrades and Downgrades

HCA has been the subject of several recent analyst reports. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.